ArticleBMJ open2022

Rescuing Cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1): protocol for a single-institution, open-label safety trial of plasma exchange to clear sPD-L1 for immunotherapy.

Tara M Davidson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.